Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Dry Eye > Botulinum toxin injections may affect tear film and ocular health over time
  • Dry Eye

Botulinum toxin injections may affect tear film and ocular health over time

Kelsey Moroz

Cosmetic botulinum toxin-A (BoNT-A) injections may impact tear film dynamics and ocular surface health, with effects changing over time. Initially, tear production appears to increase, but this is followed by potential disruptions in tear stability and a rise in dry eye symptoms in the months after treatment, according to a study.

Researchers analyzed 80 participants, dividing them into groups based on time since injection—0-1 month, 1-3 months, and 3-6 months—alongside a control group with no treatment. Key assessments included tear production (Schirmer test), tear stability, and dry eye symptoms.

There was a temporary increase in tear production shortly after injection, with the 0-1 month group having the highest Schirmer scores. However, tear stability declined, and dry eye symptoms worsened in the 1-3 and 3-6 month groups compared to controls.

Reference
Bulut M, Reyhan AH. Short-Term Effects on Tear Film Following Cosmetic Botulinum Toxin Injections in Healthy Individuals. Cureus. 2025;17(1):e77688. doi: 10.7759/cureus.77688. PMID: 39974230; PMCID: PMC11836060.

Share

Related Content

  • Dry Eye

Preservative-free lubricants linked to improved dry eye symptoms in real-world study

  • Dry Eye

Spotlight on LACRIFILL®

  • Conference Roundup

If your patient has recurrent chalazia, consider co-occurring Demodex blepharitis

  • Conference Roundup

Ocular staining and dry mouth may help identify Sjögren’s-related dry eye

  • Conference Roundup

Daily vaping associated with increased risk of ocular surface disease

  • Conference Roundup

Nearly half of eye care providers show Demodex infestation, with severity increasing over time in practice

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon